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See Article, pages 808–813Donation after cardiac death (DCD) represents a unique source to
signiﬁcantly increase organ donation.
Organ donations after cardiac death (DCD) are a potential
donor source that for years have caused great controversy due
to a higher rate of complications that result in a decreased sur-
vival rate [1]. Nevertheless, from the time the ﬁrst articles were
published, in which the possibility of using these potential
donors was broached, up to the present date, the use of organs
from this source has increased progressively [2] and, at present,
in this author’s view, offer the best chance for objectively increas-
ing the number of donors, in a setting in which the lack of organs
for all of the patients in need of a liver graft is the norm.
A number of aspects should be underlined, some of which have
been noted in the article by Jay et al. in this issue of the Journal.Differences between donor types
Not all DCD are equal. In our view, there are two main categories
that are representative of two distinctly different types.
Maastricht category III donors [3] are patients in the ICU for
whom the decision is made to withdraw life-support treatment
and for whom cardiac arrest is expected. These are donors whose
stay in the ICU has been lengthy, who have typically been fed par-
enterally and who have undergone some sort of aggressive treat-
ment whether it is surgery or multiple antibiotic treatments.
They are therefore classiﬁed as marginal or extended criteria
donors (ECD).
Then, there are Maastricht category II donors, who are people
who have undergone attempts at advanced cardiopulmonary
resuscitation that have proved unsuccessful [3]. These donors
present a totally different situation in which sudden death is
associated with failed lifesaving measures that put a person into
a position to donate, and in which long stays in the ICU are rare
and the risk of infection is highly unlikely [4,5]. Therefore, at ﬁrst
sight, these donors may be considered to be of reasonable quality.Differences in the types of procedures for obtaining organs
The handling of the donor throughout the organ retrieval process
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absence of any type of measures insofar as category III (con-
trolled) donors are concerned. Cardiac arrest is expected and if
it exceeds 30 min, most groups do not proceed with the removal.
In this sense, it is important to point out that long before cardiac
arrest happens, there is a total lack of arterial and portal blood
ﬂow through the liver [8]. Only the Michigan group associates
the use of an extracorporeal membrane oxygenation machine
(ECMO) with the whole retrieval procedure in an effort to reduce
or reverse some of the injuries that happen during this
warm ischemia time. Their results show that the use of this
device improves the quality of the organs and increases the
potential donor pool by 33% [9]. Even so, the number of
ischemic-type biliary lesions associated with this type of dona-
tion is high and is the most frequent cause for graft loss and
re-transplantation.
As far as Maastricht category II donors are concerned, world-
wide they represent a minority of all cases and the most impor-
tant aspect in which they are involved, the development of
procedures that allow the body to be preserved after death, has
been conﬁrmed through the systematic use of ECMO at 37 C
(Normothermic Recirculation, NR) [4]. Though small to date,
experience conﬁrms that it is possible to use these organs safely
and suggests that the incidence of ischemic-type biliary lesions
can be substantially reduced [5].
Normothermic Extracorporeal Machine Oxygenator (NECMO),
therefore, becomes a system that, when used after cardiac arrest
(both in category II and category III donors), is able to reduce
and even reverse injuries that occur during the warm ischemia
time. It eliminates the sense of urgency, allowing the removal
of organs to be carried out safely. Some groups have suggested
the use of substances during this period, to keep the vascular
bed intact and thus avoid ischemic injury to the biliary tract
[10].Difference in results
There is no doubt, as the authors of this study conﬁrm, that in the
present circumstances DCD is associated with lower chances of
survival and a higher rate of re-transplantation. However, as
the authors show, the survival rate for re-transplants is the same
whether the initial graft came from a DCD or a DBD. Nonetheless,
there is no question that this practice has proved to be very11 vol. 55 j 745–746
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efﬁcient and has allowed the number of patients who receive
transplants to increase. That said, both types of DCD (category
II and III) are associated with very low efﬁciency, i.e. the whole
procedure for organ retrieval is often aborted due to suspicions
about the quality of the graft [5]. This makes obvious the need
for improving the conditions surrounding organ retrieval, in
order to improve the quality of the organs harvested. This means
using some sort of device to keep the organs functioning after
removal [11–13]. Perfusion machines are nothing new, but until
now their clinical application has been negligible.
There is not yet much clinical experience. Only the Guarrera
group has used ex situ hypothermic machine perfusion on occa-
sion, on grafts that were a priori marginal, and which showed
its usefulness. The authors [14] suggest that hypothermic
machine perfusion preservation signiﬁcantly reduces pro-inﬂam-
matory cytokine expression when compared with cold storage.
Two recently published experimental studies highlight the impor-
tance of ex situ normothermic perfusion (37 C) in improving DCD
graft quality. The Oxford group designed a perfusion machine
capable of keeping the organ (after a 60 min cardiac arrest) for
20 h and achieving a survival rate of nearly 90% after transplanta-
tion [12]. Our group has also been able to verify the efﬁciency of ex
situ normothermic perfusion after 90 min of cardiac arrest and the
use of NECMO during the procedure to obtain the liver graft. In the
ﬁrst place, this experimental study underlines the importance of
using NECMO during the procedure to retrieve organs from DCD
donors, thereby conﬁrming all the previous data, and secondly,
that the chance of organ recovery, following 4 h of ex situ normo-
thermic machine perfusion (37 C), allows the achievement of a
100% post-transplant survival rate [13].
To summarize, DCDs are a unique source that could produce a
signiﬁcant increase in organ donation. Nevertheless, and accord-
ing to the authors of the paper published here, the present results
could be improved. In our opinion, mechanisms should be added
during (NECMO) and after the procedure to obtain the graft
(Hypo or Normothermic Machine Perfusion), which would clearly
improve two aspects: the overall efﬁciency of the organ retrieval
and assurance as to the quality of the organ, by preventing ische-
mic complications such as cholangiopathy.Conﬂict of interest
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